HDAC4 Cancer Research Results
HDAC4, Histone deacetylases: Click to Expand ⟱
| Source: |
| Type: |
HDAC4 overexpression is associated with higher tumor grade, advanced clinical stage and poor survival. HDAC4 promotes proliferation and G1/S cell cycle progression in EC cells by inhibiting cyclin-dependent kinase (CDK) inhibitors p21 and p27 and up-regulating CDK2/4 and CDK-dependent Rb phosphorylation.
HDAC4 is often overrepresented and associated with poor prognosis.
HDAC Inhibitors: Given the role of HDAC4 in cancer, HDAC inhibitors (HDACi) are being explored as potential therapeutic agents.
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
HT29 |
|
|
|
- |
in-vitro, |
CRC, |
HCT15 |
|
|
|
- |
in-vitro, |
CRC, |
COLO205 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCMig↓, TumCI↓, TumCG↓, TumMeta↓, Sp1/3/4↓, HDAC4↓, FAK↓, CD24↓, E-cadherin↑, EMT↓, TumCP↓, NF-kB↓, AP-1↝, STAT3↓, P53?, β-catenin/ZEB1↓, NOTCH1↝, Hif1a↝, PPARα↝, Rho↓, MMP2↓, MMP9↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
PPARα↝, 1,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
DNA Damage & Repair ⓘ
P53?, 1,
Proliferation, Differentiation & Cell State ⓘ
CD24↓, 1, EMT↓, 1, HDAC4↓, 1, NOTCH1↝, 1, STAT3↓, 1, TumCG↓, 1,
Migration ⓘ
AP-1↝, 1, E-cadherin↑, 1, FAK↓, 1, MMP2↓, 1, MMP9↓, 1, Rho↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↝, 1,
Immune & Inflammatory Signaling ⓘ
NF-kB↓, 1,
Total Targets: 22
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: HDAC4, Histone deacetylases
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:407 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page